Skip to main content

Table 5 The Minnesota Multiphasic Personality Inventory (MMPI-2) among the studied samples

From: Effect of long-term administration of clonazepam, carbamazepine, and valproate on cognitive, psychological, and personality changes in adult epilepsy: a case–control study

MMPI-2 variables

Group 1

N = 35

N (%)

Group 2

N = 18

N (%)

Group 3

N = 31

N (%)

Group 4

N = 15

N (%)

Group 5

N = 40

N (%)

P value

Hypochondriasis

 Normal

4 (11.4%)

3 (16.7%)

4 (12.9%)

0 (0%)

14 (35%)

0.000*

 Borderline

23 (65.7%)

12 (66.7%)

15 (48.4%)

15 (100%)

26 (65%)

 

 Symptomatic

8 (22.9%)

3 (16.7%)

12 (38.7%)

0 (0%)

0 (0%)

 

Depression

 Normal

14 (40%)

3 (16.7%)

1 (3.2%)

9 (60%)

30 (75%)

0.000*

 Borderline

10 (28.6%)

12 (66.7%)

14 (45.2%)

3 (20%)

10 (25%)

 

 Symptomatic

11 (31.4%)

3 (16.7%)

16 (51.6%)

3 (20%)

0 (0%)

 

Conversion hysteria

 Normal

5 (14.3%)

3 (16.7%)

4 (12.9%)

3 (20%)

17 (42.5%)

0.000*

 Borderline

21 (60%)

12 (66.7%)

12 (38.7%)

9 (60%)

23 (57.5%)

 

 Symptomatic

9 (25.7%)

3 (16.7%)

15 (48.4%)

3 (20%)

0 (0%)

 

Psychopathic Deviate

 Normal

14 (40%)

9 (50%)

6 (19.4%)

0 (0%)

33 (82.5%)

0.000*

 Borderline

20 (57.1%)

9 (50%)

18 (58.1%)

15 (100%)

7 (17.5%)

 

 Symptomatic

1 (2.9%)

0 (0%)

7 (22.6%)

0 (0%)

0 (0%)

 

Masculinity–femininity

 Normal

7 (20%)

12 (66.7%)

8 (25.8%)

0 (0%)

19 (47.5%)

0.000*

 Borderline

17 (48.6%)

6 (33.3%)

21 (67.7%)

15 (100%)

12 (30%)

 

 Symptomatic

11 (31.4%)

0 (0%)

2 (6.5%)

0 (0%)

9 (22.5%)

 

Paranoia

 Normal

20 (57.1%)

9 (50%)

9 (29%)

6 (40%)

33 (82.5%)

0.000*

 Borderline

14 (40%)

9 (50%)

14 (45.2%)

9 (60%)

6 (15%)

 

 Symptomatic

1 (2.9%)

0 (0%)

8 (25.8%)

0 (0%)

1 (2.5%)

 

Psychasthenia

 Normal

17 (48.6%)

3 (16.7%)

9 (29%)

9 (60%)

33 (82.5%)

0.000*

 Borderline

18 (51.4%)

15 (83.3%)

17 (54.8%)

6 (40%)

7 (17.5%)

 

 Symptomatic

0 (0%)

0 (0%)

5 (16.1%)

0 (0%)

0 (0%)

 

Schizophrenia

 Normal

16 (45.7%)

9 (50%)

6 (19.4%)

9 (60%)

34 (85%)

0.000*

 Borderline

14 (40%)

9 (50%)

20 (64.5%)

6 (40%)

6 (15%)

 

 Symptomatic

5 (14.3%)

0 (0%)

5 (16.1%)

0 (0%)

0 (0%)

 

Hypomania

 Normal

26 (74.3%)

6 (33.3%)

16 (51.6%)

6 (40%)

32 (80%)

0.000*

 Borderline

9 (25.7%)

12 (66.7%)

9 (29%)

9 (60%)

8 (20%)

 

 Symptomatic

0 (0%)

0 (0%)

6 (19.4%)

0 (0%)

0 (0%)

 

Social introversion

 Normal

20 (57.1%)

15 (83.3%)

8 (25.8%)

9 (60%)

36 (90%)

0.000*

 Borderline

12 (34.3%)

3 (16.7%)

18 (58.1%)

6 (40%)

4 (10%)

 

 Symptomatic

3 (8.6%)

0 (0%)

5 (16.1%)

0 (0%)

0 (0%)

 
  1. Group 1: carbamazepine, group 2: valproate, group 3: carbamazepine and clonazepam, group 4: valproate and clonazepam, group 5: epileptic patients without antiepileptic drugs (AEDs), *significant P value